High demand puts pressure on Shingrix supply chain

GSK expects to deliver 1.1 million doses of its shingles vaccine to the Commonwealth in the first half of 2024  Higher than anticipated demand for the National Immunisation Program (NIP) listed Shingrix vaccine is impacting the supply of the jab to pharmacies.  Since the launch of the NIP Vaccination in Pharmacy (NIPVIP) program on 1